Top Markets
Coin of the day
LAUNXP Biomedical Co., Ltd LAUNXP Biomedical Co., Ltd

LAUNXP Biomedical Co., Ltd

6876
Rank in Stocks #28267
LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical... LAUNXP Biomedical Co. Ltd. specializes in developing innovative pharmaceutical treatments for various types of cancer. Their product line includes therapies designed to combat tumor growth and inhibit cell proliferation, notably utilizing advanced platforms such as virus-like nanoparticles and other nanoparticle-based drug delivery systems. The company was established on September 24, 2015, and its primary corporate operations are based in Taichung, Taiwan.
Share Price
$0.3958979
Market Cap
$27.40M
Change (1 day)
-0.40%
Change (1 year)
-48.96%
Country
TW
Trade LAUNXP Biomedical Co., Ltd (6876)

Category

Dividend history for LAUNXP Biomedical Co., Ltd (6876)
LAUNXP Biomedical Co., Ltd (stock symbol: 6876) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for LAUNXP Biomedical Co., Ltd (6876) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
0.00%
US
0.00%
US
0.00%
NL
64.00%
AU
0.00%
CH